Active ingredientSolriamfetolCat. No. P-S061-001CAS 178429-62-4Family · Pharmaceutical analytical standards
Solriamfetol
A wakefulness-promoting drug that inhibits the reuptake of norepinephrine and dopamine: it was approved in the US in 2019 and in the European Union in 2020 for excessive daytime sleepiness in adults with narcolepsy or obstructive sleep apnoea. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Chemically it derives from the amino acid D-phenylalanine: its chemical name is O-carbamoyl-D-phenylalaninol. Compared with similar drugs such as modafinil and bupropion, it also acts on the TAAR1 receptor.
Go to the active ingredient →Active ingredientSolriamfetolCat. No. P-S061-001CAS 178429-62-4
Isotopically labelled(S)-Solriamfetol-d5Cat. No. P-S061-002
Isotopically labelledrac-Solriamfetol-d5Cat. No. P-S061-003
Isotopically labelledSolriamfetol-d5Cat. No. P-S061-004CAS 1910047-25-4
Impurity(R)-Solriamfetol Impurity 1Cat. No. P-S061-005CAS 102029-44-7
Impurity(S)-SolriamfetolCat. No. P-S061-006CAS 178429-63-5
ImpuritySolriamfetol Impurity FCat. No. P-S061-007CAS 275378-91-1
ImpurityPhenylalanylphenylalanine methyl ester hydrochlorideCat. No. P-S061-008CAS 38017-65-1
Impurityrac-SolriamfetolCat. No. P-S061-009CAS 178429-61-3
ImpuritySolriamfetol Impurity 2Cat. No. P-S061-010
ImpuritySolriamfetol Impurity 3Cat. No. P-S061-011
ImpuritySolriamfetol Impurity 4Cat. No. P-S061-012
ImpuritySolriamfetol Impurity 5Cat. No. P-S061-013
ImpuritySolriamfetol Impurity 6Cat. No. P-S061-014
ImpuritySolriamfetol Impurity ECat. No. P-S061-015CAS 90719-32-7No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.